Trial intelligence / Profile preview

Immune protective anesthesia during endoscopic colon surgery to improve long-term survival

2017-000867-34Phase 4Active

Sponsor
University Medical Center Groningen
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in colon cancer (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Immunological markers. Started Apr 2017; status: active.

02

Drugs

dexmedetomidine
03

Conditions

colon cancer

Beyond the preview

Go deeper on 2017-000867-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-000867-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call